Measuring glucocorticoid receptor expression in vivo with PET.

about

Measuring glucocorticoid receptor expression in vivo with PET.

Item

http://www.wikidata.org/entity/Q55248523

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Measuring glucocorticoid receptor expression in vivo with PET.

@en

Measuring glucocorticoid receptor expression in vivo with PET.

@nl

type

Item

label

Measuring glucocorticoid receptor expression in vivo with PET.

@en

Measuring glucocorticoid receptor expression in vivo with PET.

@nl

prefLabel

Measuring glucocorticoid receptor expression in vivo with PET.

@en

Measuring glucocorticoid receptor expression in vivo with PET.

@nl

P1476

Measuring glucocorticoid receptor expression in vivo with PET

@en

P2093

David M Wilson

http://www.w3.org/2001/XMLSchema#string

John Kurhanewicz

http://www.w3.org/2001/XMLSchema#string

Junnian Wei

http://www.w3.org/2001/XMLSchema#string

Loc T Huynh

http://www.w3.org/2001/XMLSchema#string

Matthew F L Parker

http://www.w3.org/2001/XMLSchema#string

Michael J Evans

http://www.w3.org/2001/XMLSchema#string

Renuka Sriram

http://www.w3.org/2001/XMLSchema#string

Yung-Hua Wang

http://www.w3.org/2001/XMLSchema#string

Yuqin S Shen

http://www.w3.org/2001/XMLSchema#string

P2860

Annotating STEAP1 regulation in prostate cancer with 89Zr immuno-PET

The biology of the glucocorticoid receptor: new signaling mechanisms in health and disease

Adrenal steroid receptors and actions in the nervous system.

Glucocorticoid receptor confers resistance to antiandrogens by bypassing androgen receptor blockade.

The preliminary study of 16α-[18F]fluoroestradiol PET/CT in assisting the individualized treatment decisions of breast cancer patients.

Noninvasive measurement of androgen receptor signaling with a positron-emitting radiopharmaceutical that targets prostate-specific membrane antigen

Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.

Activation of the glucocorticoid receptor is associated with poor prognosis in estrogen receptor-negative breast cancer.

Assessment of progesterone receptors in breast carcinoma by PET with 21-18F-fluoro-16α,17α-[(R)-(1'-α-furylmethylidene)dioxy]-19-norpregn-4-ene-3,20-dione.

P304

20399-20408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.24911

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Charles Truillet

Khaled M Jami

P577

2018-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29755660

http://www.w3.org/2001/XMLSchema#string

P932

5945515

http://www.w3.org/2001/XMLSchema#string